Clinical Trials Logo

Von Hippel clinical trials

View clinical trials related to Von Hippel.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03108066 Completed - Clinical trials for Clear Cell Renal Cell Carcinoma

PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma

Start date: April 24, 2017
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to assess the overall response rate (ORR) of von Hippel-Lindau (VHL) disease-associated clear cell renal cell carcinoma (ccRCC) tumors in VHL patients treated with PT2385.